메뉴 건너뛰기




Volumn 10, Issue 2, 2008, Pages 52-55

Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: A retrospective analysis of 1085 infusions

Author keywords

High dose IVIG; Home infusion; Immunoglobulin home infusion; Intravenous immunoglobulin; IVIG; IVIG home infusion; Neuroimmunologic disease; Neuropathy

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

EID: 64049109358     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31818b2aef     Document Type: Article
Times cited : (14)

References (7)
  • 1
    • 3042856624 scopus 로고    scopus 로고
    • The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Evidence-based indications and safety profile
    • Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther. 2004;102:177-193.
    • (2004) Pharmacol Ther , vol.102 , pp. 177-193
    • Dalakas, M.C.1
  • 2
    • 84865371293 scopus 로고    scopus 로고
    • IVIg in idiopathic autoimmune neuropathies: Analysis in the light of the latest results
    • Nobile-Orazio E, Terenghi F. IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results. J Neurol. 2005;252(Suppl 1):7-3.
    • (2005) J Neurol , vol.252 , Issue.SUPPL. 1 , pp. 7-3
    • Nobile-Orazio, E.1    Terenghi, F.2
  • 3
    • 33846080463 scopus 로고    scopus 로고
    • Drug insight: The use of intravenous immunoglobulin in neurology-therapeutic considerations and practical issues
    • Gold R, Stangel M, Dalakas M. Drug insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and practical issues. Nat Clin Pract Neurol. 2007;3:36-44.
    • (2007) Nat Clin Pract Neurol , vol.3 , pp. 36-44
    • Gold, R.1    Stangel, M.2    Dalakas, M.3
  • 4
    • 0031051617 scopus 로고    scopus 로고
    • Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases
    • Schiff RI, Williams LW, Nelson RP, et al. Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases. J Clin Immunol. 1997;17: 21-28.
    • (1997) J Clin Immunol , vol.17 , pp. 21-28
    • Schiff, R.I.1    Williams, L.W.2    Nelson, R.P.3
  • 5
    • 0142178203 scopus 로고    scopus 로고
    • Risks associated with the use of intravenous immunoglobulin
    • Pierce LR, Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus Med Rev. 2003;17:241-251.
    • (2003) Transfus Med Rev , vol.17 , pp. 241-251
    • Pierce, L.R.1    Jain, N.2
  • 6
    • 33645341439 scopus 로고    scopus 로고
    • Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
    • Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117(Suppl):S525-S553.
    • (2006) J Allergy Clin Immunol , vol.117 , Issue.SUPPL.
    • Orange, J.S.1    Hossny, E.M.2    Weiler, C.R.3
  • 7
    • 0036179368 scopus 로고    scopus 로고
    • Home sequential high dose intravenous immunoglobulins in systemic autoimmune disease
    • Hachulla E, Wibaux A, Hatron PY, et al. Home sequential high dose intravenous immunoglobulins in systemic autoimmune disease. Ann Rheum Dis. 2008;61:277-278.
    • (2008) Ann Rheum Dis , vol.61 , pp. 277-278
    • Hachulla, E.1    Wibaux, A.2    Hatron, P.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.